Literature DB >> 2807708

Trends in CHD in the United States.

M Higgins1, T Thom.   

Abstract

Coronary heart disease (CHD) death rates increased in the United States until the mid 1960s then declined. Declines were greater for acute myocardial infarction (AMI), for younger age groups, for the white population, and for higher socioeconomic groups. Trends in incidence are uncertain but in-hospital fatality rates have decreased. There have been major advances in diagnosis, prevention and treatment of CHD, and numbers of internists and cardiologists, emergency medical services, and coronary care units have increased. New potent medical and surgical treatments for acute and chronic CHD have been introduced. Reductions in risk factors include decreases in cigarette smoking especially among men, falls in mean systolic blood pressure, rises in the proportion of hypertensive adults who are treated and controlled, and reductions in plasma cholesterol. Consumption of whole milk, butter, and eggs decreased whereas use of low fat milk, cooking oils, poultry, fish, vegetables, and fruits increased. However, the prevalence of obesity has increased. CHD is still the leading cause of death, and its prevalence is expected to rise as the population increases at older ages and treatment prolongs survival of patients with CHD.

Entities:  

Mesh:

Year:  1989        PMID: 2807708

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  10 in total

Review 1.  Cardiovascular disease and risk factor epidemiology: a look back at the epidemic of the 20th century.

Authors:  F J Nieto
Journal:  Am J Public Health       Date:  1999-03       Impact factor: 9.308

Review 2.  Dissecting the genetic contribution to coronary heart disease.

Authors:  J W MacCluer; C M Kammerer
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

3.  Cardiovascular risk factor awareness in a disadvantaged inner-city population--implications for preventive strategies.

Authors:  Brian M Wong; Yelian Garcia; Aiala Barr; Richard H Glazier; Beth L Abramson
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

4.  Distribution of cardiovascular disease risk factors by socioeconomic status among Canadian adults.

Authors:  R Choinière; P Lafontaine; A C Edwards
Journal:  CMAJ       Date:  2000       Impact factor: 8.262

5.  Knowledge of cardiovascular disease risk factors among the Canadian population: relationships with indicators of socioeconomic status.

Authors:  L Potvin; L Richard; A C Edwards
Journal:  CMAJ       Date:  2000       Impact factor: 8.262

6.  The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I. Pleiotropic effects on means and variances.

Authors:  S L Reilly; R E Ferrell; B A Kottke; M I Kamboh; C F Sing
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

7.  The decline and rise of coronary heart disease: understanding public health catastrophism.

Authors:  David S Jones; Jeremy A Greene
Journal:  Am J Public Health       Date:  2013-05-16       Impact factor: 9.308

8.  Excess mortality among cigarette smokers: changes in a 20-year interval.

Authors:  M J Thun; C A Day-Lally; E E Calle; W D Flanders; C W Heath
Journal:  Am J Public Health       Date:  1995-09       Impact factor: 9.308

9.  Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the non-communicable disease intervention programme in Mauritius. Mauritius Non-communicable Disease Study Group.

Authors:  G K Dowse; H Gareeboo; K G Alberti; P Zimmet; J Tuomilehto; A Purran; D Fareed; P Chitson; V R Collins
Journal:  BMJ       Date:  1995-11-11

Review 10.  Challenges of ascertaining national trends in the incidence of coronary heart disease in the United States.

Authors:  Earl S Ford; Véronique L Roger; Shannon M Dunlay; Alan S Go; Wayne D Rosamond
Journal:  J Am Heart Assoc       Date:  2014-12-03       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.